Disrupted Excitation-inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease

Overview

Journal bioRxiv

Date 2023 Sep 4

PMID 37662359

Authors

Igor Fortel

Liang Zhan

Olusola Ajilore

Yichao Wu

Scott Mackin

Alex Leow

Affiliations

Soon will be listed here.

Abstract

Background: Sex differences impact Alzheimer's disease (AD) neuropathology, but cell-to-network level dysfunctions in the prodromal phase are unclear. Alterations in hippocampal excitation-inhibition balance (EIB) have recently been linked to early AD pathology.

Objective: Examine how AD risk factors (age, APOE-ɛ4, amyloid-β) relate to hippocampal EIB in cognitively normal males and females using connectome-level measures.

Methods: Individuals from the OASIS-3 cohort (age 42-95) were studied (N = 437), with a subset aged 65+ undergoing neuropsychological testing (N = 231).

Results: In absence of AD risk factors (APOE-ɛ4/Aβ+), whole-brain EIB decreases with age more significantly in males than females (p = 0.021, β = -0.007). Regression modeling including APOE-ɛ4 allele carriers (Aβ-) yielded a significant positive AGE-by-APOE interaction in the right hippocampus for females only (p = 0.013, β = 0.014), persisting with inclusion of Aβ+ individuals (p = 0.012, β = 0.014). Partial correlation analyses of neuropsychological testing showed significant associations with EIB in females: positive correlations between right hippocampal EIB with categorical fluency and whole-brain EIB with the trail-making test (p < 0.05).

Conclusion: Sex differences in EIB emerge during normal aging and progresses differently with AD risk. Results suggest APOE-ɛ4 disrupts hippocampal balance more than amyloid in females. Increased excitation correlates positively with neuropsychological performance in the female group, suggesting a duality in terms of potential beneficial effects prior to cognitive impairment. This underscores the translational relevance of APOE-ɛ4 related hyperexcitation in females, potentially informing therapeutic targets or early interventions to mitigate AD progression in this vulnerable population.

References

Altmann A, Tian L, Henderson V, Greicius M . Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75(4):563-73. PMC: 4117990. DOI: 10.1002/ana.24135. View

Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002; 15(1):273-89. DOI: 10.1006/nimg.2001.0978. View

Sen A, Akinola M, Tai X, Symmonds M, Jones G, Mura S . An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study. Trials. 2021; 22(1):508. PMC: 8325256. DOI: 10.1186/s13063-021-05404-4. View

Cotelli M, Calabria M, Manenti R, Rosini S, Zanetti O, Cappa S . Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry. 2010; 82(7):794-7. DOI: 10.1136/jnnp.2009.197848. View

Morris J . The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43(11):2412-4. DOI: 10.1212/wnl.43.11.2412-a. View

Li J, Park E, Zhong L, Chen L . Homeostatic synaptic plasticity as a metaplasticity mechanism - a molecular and cellular perspective. Curr Opin Neurobiol. 2018; 54:44-53. PMC: 6361678. DOI: 10.1016/j.conb.2018.08.010. View

Perica M, Calabro F, Larsen B, Foran W, Yushmanov V, Hetherington H . Development of frontal GABA and glutamate supports excitation/inhibition balance from adolescence into adulthood. Prog Neurobiol. 2022; 219:102370. DOI: 10.1016/j.pneurobio.2022.102370. View

Korthauer L, Zhan L, Ajilore O, Leow A, Driscoll I . Disrupted topology of the resting state structural connectome in middle-aged APOE ε4 carriers. Neuroimage. 2018; 178:295-305. PMC: 6249680. DOI: 10.1016/j.neuroimage.2018.05.052. View

Raber J, Huang Y, Ashford J . ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004; 25(5):641-50. DOI: 10.1016/j.neurobiolaging.2003.12.023. View

10.

Zanoci C, Dehghani N, Tegmark M . Ensemble inhibition and excitation in the human cortex: An Ising-model analysis with uncertainties. Phys Rev E. 2019; 99(3-1):032408. DOI: 10.1103/PhysRevE.99.032408. View

11.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

12.

Ashourvan A, Gu S, Mattar M, Vettel J, Bassett D . The energy landscape underpinning module dynamics in the human brain connectome. Neuroimage. 2017; 157:364-380. PMC: 5600845. DOI: 10.1016/j.neuroimage.2017.05.067. View

13.

Targa Dias Anastacio H, Matosin N, Ooi L . Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?. Transl Psychiatry. 2022; 12(1):257. PMC: 9217953. DOI: 10.1038/s41398-022-02024-7. View

14.

Gallagher M, Okonkwo O, Resnick S, Jagust W, Benzinger T, Rapp P . What are the threats to successful brain and cognitive aging?. Neurobiol Aging. 2019; 83:130-134. PMC: 6859944. DOI: 10.1016/j.neurobiolaging.2019.04.016. View

15.

Burke S, Barnes C . Neural plasticity in the ageing brain. Nat Rev Neurosci. 2005; 7(1):30-40. DOI: 10.1038/nrn1809. View

16.

Valencia-Olvera A, Maldonado Weng J, Christensen A, LaDu M, Pike C . Role of estrogen in women's Alzheimer's disease risk as modified by APOE. J Neuroendocrinol. 2022; 35(2):e13209. PMC: 10049970. DOI: 10.1111/jne.13209. View

17.

Farrer L, Cupples L, Haines J, Hyman B, Kukull W, Mayeux R . Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997; 278(16):1349-56. View

18.

Veitch D, Weiner M, Aisen P, Beckett L, Cairns N, Green R . Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2018; 15(1):106-152. DOI: 10.1016/j.jalz.2018.08.005. View

19.

Nelson S, Valakh V . Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders. Neuron. 2015; 87(4):684-98. PMC: 4567857. DOI: 10.1016/j.neuron.2015.07.033. View

20.

Woitowich N, Woodruff T . Opinion: Research community needs to better appreciate the value of sex-based research. Proc Natl Acad Sci U S A. 2019; 116(15):7154-7156. PMC: 6462069. DOI: 10.1073/pnas.1903586116. View